ConductScience.org, home

Paper32034142

CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide.

Radhakrishnan SV and 13 others. Nat Commun, 2020. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide. Papers, record 32034142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32034142

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide.
PubMed
Journal
Nat Commun
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
2.74
iCite
Revised in PubMed
2021-02-06
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Radhakrishnan SVSabarinath V
2Luetkens TTimhttps://orcid.org/0000-0002-7085-9027
3Scherer SDSandra D
4Davis PPatricia
5Vander Mause ERErica R
6Olson MLMichael Lhttps://orcid.org/0000-0002-1566-2029
7Yousef SSara
8Panse JJens
9Abdiche YYasmina
10Li KDK David
11Miles RRRodney R
12Matsui WWilliam
13Welm ALAlana L
14Atanackovic DDjordje

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunotherapy, AdoptiveMajor topic
Multiple MyelomaMajor topic
Receptors, Antigen, T-CellMajor topic
Signaling Lymphocytic Activation Molecule FamilyMajor topic
Animals
Antibodies
B-Lymphocytes
Humans
K562 Cells
Male
Mice, Inbred NOD
T-Lymphocytes
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K24 CA198315NCI NIH HHSUnited StatesK24CA198315PubMed and NIHNIH RePORTER
P30 CA042014NCI NIH HHSUnited StatesP30CA042014PubMed and NIHNIH RePORTER

Download CSV of grants

References2

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112374689Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.Clin Cancer Res2002https://conductscience.org/library/papers/12374689PubMed
228861320CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.Am J Cancer Res2017https://conductscience.org/library/papers/28861320PubMed

Download CSV of references

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42020353Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42020353PubMed
41271617Defining the proteome of bone marrow plasma in multiple myeloma and monoclonal gammopathy of undetermined significance.Blood Cancer J2025https://conductscience.org/library/papers/41271617PubMed
41052980Investigation of lncRNA expression in newly diagnosed multiple myeloma reveals a LINC01432-CELF2 axis as an inhibitor of apoptosis.Oncogenesis2025https://conductscience.org/library/papers/41052980PubMed
40597436Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential.Biomark Res2025https://conductscience.org/library/papers/40597436PubMed
40400956Identification of potential therapeutic drug targets for sepsis by combining the human plasma proteome and genome: a Mendelian randomization study.J Thorac Dis2025https://conductscience.org/library/papers/40400956PubMed
40382610SLAMF receptors: key regulators of tumor progression and emerging targets for cancer immunotherapy.Mol Cancer2025https://conductscience.org/library/papers/40382610PubMed
40264764Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias.Front Immunol2025https://conductscience.org/library/papers/40264764PubMed
39816951Development and Validation of a Diagnostic Model for Stanford Type B Aortic Dissection Based on Proteomic Profiling.J Inflamm Res2025https://conductscience.org/library/papers/39816951PubMed
39558776Are we there yet? CAR-T therapy in multiple myeloma.Br J Haematol2024https://conductscience.org/library/papers/39558776PubMed
39468695Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma.Exp Hematol Oncol2024https://conductscience.org/library/papers/39468695PubMed
39372412Generating advanced CAR-based therapy for hematological malignancies in clinical practice: targets to cell sources to combinational strategies.Front Immunol2024https://conductscience.org/library/papers/39372412PubMed
39095991T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting.Mol Ther2024https://conductscience.org/library/papers/39095991PubMed
38986621Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity.Cell Rep Med2024https://conductscience.org/library/papers/38986621PubMed
38915559Preventing trogocytosis by cathepsin B inhibition augments CAR T cell function.bioRxiv2025https://conductscience.org/library/papers/38915559PubMed
38892913CAR-T-Cell-Based Cancer Immunotherapies: Potentials, Limitations, and Future Prospects.J Clin Med2024https://conductscience.org/library/papers/38892913PubMed
38865708Beyond BCMA: newer immune targets in myeloma.Blood Adv2024https://conductscience.org/library/papers/38865708PubMed
38800372Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma.Front Oncol2024https://conductscience.org/library/papers/38800372PubMed
38699030From spear to trident: Upgrading arsenal of CAR-T cells in the treatment of multiple myeloma.Heliyon2024https://conductscience.org/library/papers/38699030PubMed
38579288IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model.Blood2024https://conductscience.org/library/papers/38579288PubMed
38502423Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma.Discov Oncol2024https://conductscience.org/library/papers/38502423PubMed

See all 45 cited byDownload CSV of cited by

Genes23

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CARTPT9607PubTator's text mininghttps://conductscience.org/library/genes/9607NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD247919PubTator's text mininghttps://conductscience.org/library/genes/919NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD33945PubTator's text mininghttps://conductscience.org/library/genes/945NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
EEF1A21917PubTator's text mininghttps://conductscience.org/library/genes/1917NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IGHV3-69-128402PubTator's text mininghttps://conductscience.org/library/genes/28402NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
LY94063PubTator's text mininghttps://conductscience.org/library/genes/4063NCBI Gene
NCAM14684PubTator's text mininghttps://conductscience.org/library/genes/4684NCBI Gene
NR1I39970PubTator's text mininghttps://conductscience.org/library/genes/9970NCBI Gene
PTPRC5788PubTator's text mininghttps://conductscience.org/library/genes/5788NCBI Gene
SCFV652070PubTator's text mininghttps://conductscience.org/library/genes/652070NCBI Gene

See all 23 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32034142

GET https://conductscience.org/api/papers/v1/32034142/cited_by?page=2